Christie Adds CounterAct UR10 to Line of Commercial UVC Disinfection Light Fixtures for Occupied Indoor Spaces

WHAT'S HAPPENING NOW:

SUBSCRIBE TO MAGAZINE

Exhibiting &
Event Topics

EXHIBITOR
Magazine

Find It
Marketplace

EXHIBITOR
LIVE

EXHIBITOR
Education Week

Venues
& Destinations

EXHIBITOR
News

trending

Sponsored Content
Ideas to Revolutionize Your Breakout Sessions

EXHIBITOR News
David DuBois Announces Retirement as President of Exhibitor Group After Distinguished Career

Company News
Maritz Acquires Convention Data Services from Freeman

EXHIBITOR News
Valerie Kliskey, CTSM, Earns Diamond-level Certified Trade Show Marketer Credentials

Shows & Events
Marketplace Events Acquires 31 Shows from Master Promotions in Largest Acquisition to Date

New Products
GruvCard Introduces Interactive Trade Show Booth Sign System

Sponsored Content
Ideas to Revolutionize Your Breakout Sessions

People
Javits Center CEO Alan Steel Announces Retirement

New Products
ExhibitDay Launches Tools for Exhibitors to Track Event Objectives and Measure Return on Objective

submit your news

email newsletter

New Products
Christie Adds CounterAct UR10 to Line of Commercial UVC Disinfection Light Fixtures for Occupied Indoor Spaces

10/18/2022
CYPRESS, Calif – As we continue to see relaxed COVID-19 restrictions — leaving the onus of safety in the hands of business operators, owners and facilities managers — global visual technologies company Christie® is pleased to introduce its newest CE- and UL- certified commercial UVC-LED disinfection light fixture for occupied, indoor spaces. Christie CounterAct™ UR10 with UVC-LED and patented Care222® far-UVC - plus visible light, in a single unit, is recommended for commercial offices, government facilities, schools, transit hubs, retail shops, medical buildings — for enhanced and safe airborne and surface disinfection wherever people gather indoors, in public places.

CounterAct UR10 builds on the release of the CA20, Christie’s first far-UVC disinfection fixture, and the desire among global business and government leaders to increase confidence and improve wellbeing in our indoor spaces, such as meeting rooms, classrooms, and other places people gather. Combining filtered Care222® far-UVC light with upper room high-power mercury-free UVC-LED, CounterAct UR10 is an evolution in technology for treating both surfaces and air in occupied indoor spaces.

The new reality is that on average we’re seeing a pandemic arise every four years since the year 20001. This trend indicates the 2023 common cold, flu season and the next pandemic are right around the corner. This is why the U.S. government is committing, through the American Rescue Plan, a total of USD$472 billion2 for schools as well as state, local, and tribal governments which can be used to deploy systems such as CounterAct UR10 UVC disinfection light fixtures.

“With our latest addition to the Christie CounterAct line of UVC disinfection fixtures, we are excited to continue to help organizations create greater confidence in indoor spaces as we return to in-person interaction,” said Brent Peckover, director, industrial applications, Christie. “The high-power upper room ultra-violet germicidal irradiation (UVGI) disinfection performance of UR10, combined with visible light capabilities to light your space, allows businesses to replace existing commercial light fixtures as a cost-effective solution.”

CounterAct UR10, which kills both airborne and surface pathogens, can be installed in rooms with ceiling heights between 9 and 22 feet (3-7.6m), includes remote control features with iOS and Android support, and can be integrated with building automation/management systems. Peckover explains, “UVC disinfection systems should be seamless and require no day-to-day user interaction while effectively inactivating pathogens in the occupied space.”

About Christie®
Christie Digital Systems USA, Inc. is a global visual and audio technologies company and a wholly owned subsidiary of Ushio Inc., Japan (JP: 6925). Christie revolutionized the movie industry with the launch of digital cinema projection, and since 1929 has embraced innovation and broken many technology barriers. Our technology, paired with the support of professional services to design, deploy and maintain installations, inspires exceptional experiences. Christie solutions are used around the world, from the largest mega-events to the smallest boardrooms, and include advanced RGB pure laser projection, SDVoE technology, content management, image processing, LED displays, and Christie CounterAct™ far-UVC disinfection solution with patented Care222® technology. Visit www.christiedigital.com.

1 “Visualizing the History of Pandemics,” Visual Capitalist, March 14, 2020.
2 “Fact Sheet: Biden Administration Launches Effort to Improve Ventilation and Reduce the Spread of COVID-19 in Buildings,” The White House Briefing Room, March 17, 2022

Notes:

*All references to “disinfect”, “disinfecting” and “disinfection” refer generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition as may be used by any governmental or regulatory authority including the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency.

The pathogen-reducing efficacy of Christie CounterAct products and their use in occupied spaces is dependent on many site-specific factors as well as proper installation and operation within specifications and in accordance with American Conference of Governmental Institutional Hygienist (ACGIH) guidelines.

Ushio’s Care222® filtered Far UV-C technology (“Care222 Technology”) is protected under U.S. and non-U.S. patents. Christie has filed one or more patent application(s) related to technical innovations in the Christie CounterAct UR10.

Contact:
questions@exhibitormagazine.com